Previous close | 4.2000 |
Open | 4.1000 |
Bid | 3.8000 |
Ask | 4.9000 |
Strike | 110.00 |
Expiry date | 2024-06-21 |
Day's range | 3.7000 - 4.2000 |
Contract range | N/A |
Volume | |
Open interest | 182 |
AUSTIN, Texas, May 23, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that the company, along with its collaborators, will present new data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 31 – June 4, 2024.
On May 15, 2024, Steven Chapman, CEO and President of Natera Inc (NASDAQ:NTRA), executed a sale of 6,779 shares of the company.
Insightful Analysis of Natera Inc's Financial Health and Market Position